|

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

RECRUITINGN/ASponsored by M.D. Anderson Cancer Center
Actively Recruiting
PhaseN/A
SponsorM.D. Anderson Cancer Center
Started2026-02-02
Est. completion2030-05-31
Eligibility
Age18 Years+
SexMALE
Healthy vol.Accepted
Locations1 site

Summary

This clinical trial identifies factors associated with completing genetic testing, aids in the development of a decision support tool, and tests how well the decision support tool works to enhance germline genetic testing in patients with prostate cancer. Germline genetic testing is a guideline-recommended standard of care for many patients with prostate cancer. Completing genetic testing can enable the use of targeted therapies, offers access to novel clinical trials, provides valuable information, and can help identify at risk family members. The decision support tool may educate patients and assist in the decision to engage with germline genetic testing.

Eligibility

Age: 18 Years+Sex: MALEHealthy volunteers accepted
Inclusion Criteria:

* Diagnosed prostate cancer patients receiving care at Lyndon B. Johnson (LBJ) Hospital
* Were recommended for germline genetic testing by their oncology provider
* Can provide informed consent
* Can communicate in English or Spanish

Exclusion Criteria:

* Prostate cancer patients receiving care at LBJ who are unable to participate due to a serious psychological or cognitive condition

Conditions2

CancerProstate Carcinoma

Locations1 site

M D Anderson Cancer Center
Houston, Texas, 77030
Debanjan Pain713-563-0020DPain@mdanderson.org

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.